LONDON, March 2, 2015 /PRNewswire/ --
The Economist Events' 21st Annual Pharma Summit held in London last week on 26 February was host to some of the industry's most high-profile leaders who offered their perspectives on a number of topical issues facing the sector. This year's theme, 'The Dawn of a New Era', observed the challenges the industry is facing as well as the innovation required to tackle them.
Panel speakers offered contrasting and thought-provoking commentary on how to deal with the most pressing of sector trends leading to lively debate amongst the packed room of delegates. Topics covered included improving access and affordability of medicines, combating healthcare issues such as diabetes and antibiotic resistance, using technology effectively to help create a more valuable healthcare system and enhancing partnerships across the ecosystem to benefit all.
This year's Pharma Summit was attended by almost 200 people which included a mix of industry leaders, stakeholders, and high quality national and international media.
Sir Michael Hirst, President, International Diabetes Federation, commented: "Collaboration between stakeholders in this industry and a creation of ecosystems will improve healthcare systems and quality of life for patients.
"We are delighted to participate in this event which provides a timely generation of ideas and potential solutions to manage and prevent public health challanges such as diabetes."
David Solomon, Chief Executive Officer, Bionor Pharma, said: "Prices going down is perfect for innovation and adds new opportunities. These pressures for new biologics and biosimilars are good - they will drive new value and really are disruptive."
To read full press release, please click here.
Help employers find you! Check out all the jobs and post your resume.
The Economist Events' 21st Annual Pharma Summit held in London last week on 26 February was host to some of the industry's most high-profile leaders who offered their perspectives on a number of topical issues facing the sector. This year's theme, 'The Dawn of a New Era', observed the challenges the industry is facing as well as the innovation required to tackle them.
Panel speakers offered contrasting and thought-provoking commentary on how to deal with the most pressing of sector trends leading to lively debate amongst the packed room of delegates. Topics covered included improving access and affordability of medicines, combating healthcare issues such as diabetes and antibiotic resistance, using technology effectively to help create a more valuable healthcare system and enhancing partnerships across the ecosystem to benefit all.
This year's Pharma Summit was attended by almost 200 people which included a mix of industry leaders, stakeholders, and high quality national and international media.
Sir Michael Hirst, President, International Diabetes Federation, commented: "Collaboration between stakeholders in this industry and a creation of ecosystems will improve healthcare systems and quality of life for patients.
"We are delighted to participate in this event which provides a timely generation of ideas and potential solutions to manage and prevent public health challanges such as diabetes."
David Solomon, Chief Executive Officer, Bionor Pharma, said: "Prices going down is perfect for innovation and adds new opportunities. These pressures for new biologics and biosimilars are good - they will drive new value and really are disruptive."
To read full press release, please click here.
Help employers find you! Check out all the jobs and post your resume.
